Reviewing PacificHealth Laboratories (OTCMKTS:PHLI) & Cresco Labs (OTCMKTS:CRLBF)

Cresco Labs (OTCMKTS:CRLBF) and PacificHealth Laboratories (OTCMKTS:PHLI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Cresco Labs and PacificHealth Laboratories, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cresco Labs	0	2	2	2	3.00
PacificHealth Laboratories	0	0	0	0	N/A

Cresco Labs currently has a consensus target price of $2.50, indicating a potential upside of 52.44%.

Profitability

This table compares Cresco Labs and PacificHealth Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cresco Labs	-23.07%	-17.03%	-5.13%
PacificHealth Laboratories	N/A	N/A	N/A

Earnings & Valuation

This table compares Cresco Labs and PacificHealth Laboratories”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cresco Labs	$770.89 million	1.04	-$175.52 million	($0.47)	-3.49
PacificHealth Laboratories	N/A	N/A	N/A	N/A	N/A

PacificHealth Laboratories has lower revenue, but higher earnings than Cresco Labs.

Institutional and Insider Ownership

0.1% of Cresco Labs shares are held by institutional investors. 38.0% of PacificHealth Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

About PacificHealth Laboratories

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.